Oxygen and the liberation of placental factors responsible for vascular compromise

Laboratory Investigation

Volumn 88, Issue 3, 2008, Pages 293-305

  Robinson, Nicola J ^a   Wareing, Mark ^a   Hudson, Nicola K ^a   Blankley, Richard T ^a   Baker, Philip N ^a   Aplin, John D ^a   Crocker, Ian P ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Endothelium; Explant; Oxygen; Placenta; Pre eclampsia; Vascular

Indexed keywords

ADENOSINE TRIPHOSPHATE; ALDEHYDE DEHYDROGENASE ISOENZYME 2; ENDOTHELIN 1; OXIDOREDUCTASE; OXYGEN; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1;

ANGIOGENESIS; APOPTOSIS; ARTICLE; CELL DEATH; CELL METABOLISM; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPEROXIA; HYPOXIA; MICROVASCULATURE; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL MEMBRANE POTENTIAL; MYOGRAPHY; MYOMETRIUM; NECROSIS; PLACENTA VILLUS; PREECLAMPSIA; PRIORITY JOURNAL; UTERINE BLOOD VESSEL; VASOCONSTRICTION;

ANOXIA; APOPTOSIS; ARGININE VASOPRESSIN; BENZIMIDAZOLES; BRADYKININ; CARBOCYANINES; CELLS, CULTURED; CHORIONIC VILLI; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIN-1; ENDOTHELIUM, VASCULAR; EPOPROSTENOL; FEMALE; FORMAZANS; HUMANS; HYPEROXIA; MEMBRANE POTENTIALS; MITOCHONDRIA; MYOMETRIUM; NECROSIS; NEOVASCULARIZATION, PHYSIOLOGIC; OXYGEN; PLACENTA; PREGNANCY; TETRAZOLIUM SALTS; VASODILATOR AGENTS;

EID: 39749146359     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.3700746     Document Type: Article

References (50)

1. Baker PN, Davidge ST, Barankiewicz J, et al. Plasma of preeclamptic women stimulates and then inhibits endothelial prostacyclin. Hypertension 1996;27:56-61.
2. Baker PN, Davidge ST, Roberts JM. Plasma from women with preeclampsia increases endothelial cell nitric oxide production. Hypertension 1995;26:244-248.
3. Ashworth JR, Warren AY, Johnson IR, et al. Plasma from pre-eclamptic women and functional change in myometrial resistance arteries. Br J Obstet Gynaecol 1998;105:459-461.
4. Aalkjaer C, Danielsen H, Johannesen P, et al. Abnormal vascular function and morphology in pre-eclampsia: a study of isolated resistance vessels. Clin Sci (Lond) 1985;69:477-482.
5. Hayman R, Warren A, Brockelsby J, et al. Plasma from women with pre-eclampsia induces an in vitro alteration in the endothelium-dependent behaviour of myometrial resistance arteries. BJOG 2000;107:108-115.
6. Chappell L, Bewley S. Pre-eclamptic toxaemia: the role of uterine artery Doppler. Br J Obstet Gynaecol 1998;105:379-382.
7. Huppertz B, Kingdom J, Caniggia I, et al. Hypoxia favours necrotic versus apoptotic shedding of placental syncytiotrophoblast into the maternal circulation. Placenta 2003;24:181-190.
8. Alsat E, Wyplosz P, Malassine A, et al. Hypoxia impairs cell fusion and differentiation process in human cytotrophoblast, in vitro. J Cell Physiol 1996;168:346-353.
9. Blumenstein M, Mitchell MD, Groome NP, et al. Hypoxia inhibits activin A production by term villous trophoblast in vitro. Placenta 2002;23:735-741.
10. Kudo Y, Boyd CA, Sargent IL, et al. Hypoxia alters expression and function of syncytin and its receptor during trophoblast cell fusion of human placental BeWo cells: implications for impaired trophoblast syncytialisation in pre-eclampsia. Biochim Biophys Acta 2003;1638:63-71.
11. Nagamatsu T, Fujii T, Kusumi M, et al. Cytotrophoblasts upregulate soluble fms-like tyrosine kinase-1 expression under reduced oxygen: an implication for the placental vascular development and the pathophysiology of preeclampsia. Endocrinology 2004;145:4838-4845.
12. Nevo O, Soleymanlou N, Wu Y, et al. Increased expression of sFlt-1 in in vivo and in vitro models of human placental hypoxia is mediated by HIF-1. Am J Physiol Regul Integr Comp Physiol 2006;291:R1085-R1093.
13. Levine RJ, Maynard SE, Qian C, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004;350:672-683.
14. Maynard SE, Min JY, Merchan J, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003;111:649-658.
15. Hayman R, Warren A, Johnson I, et al. The preliminary characterization of a vasoactive circulating factor(s) in preeclampsia. Am J Obstet Gynecol 2001;184:1196-1203.
16. Anderson NL, Anderson NG. The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics 2002;1:845-867.
17. Robinson NJ, Sheikh NA, Baker PN, et al. A serum free in vitro model for the investigation of placental-derived pathogenic factors in preeclampsia. Hypertension Pregnancy 2006;25(Supplement 1): 57 abstract O075.
18. Crocker IP, Tansinda DM, Jones CJ, et al. The influence of oxygen and tumor necrosis factor-alpha on the cellular kinetics of term placental villous explants in culture. J Histochem Cytochem 2004;52:749-757.
19. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55-63.
20. Padavala S, Pope N, Baker P, et al. An imbalance between vascular endothelial growth factor and its soluble receptor in placental villous explants of intrauterine growth-restricted pregnancies. J Soc Gynecol Investig 2006;13:40-47.
21. Wareing M, Crocker IP, Warren AY, et al. Characterization of small arteries isolated from the human placental chorionic plate. Placenta 2002;23:400-409.
22. Wareing M, Greenwood SL, Taggart MJ, et al. Vasoactive responses of veins isolated from the human placental chorionic plate. Placenta 2003;24:790-796.
23. Green LC, Wagner DA, Glogowski J, et al. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem 1982;126:131-138.
24. Fujikura T, Yoshida J. Blood gas analysis of placental and uterine blood during Cesarean delivery. Obstet Gynecol 1996;87:133-136.
25. Hung TH, Skepper JN, Burton GJ. In vitro ischemia-reperfusion injury in term human placenta as a model for oxidative stress in pathological pregnancies. Am J Pathol 2001;159:1031-1043.
26. Arechavaleta-Velasco F, Hernandez-Guerrero C, Ahued-Ahued R, et al. Evidence of endothelial cytotoxic compounds in placental extracts from preeclamptic women. J Soc Gynecol Investig 2000;7:114-117.
27. Marchetti P, Castedo M, Susin SA, et al. Mitochondrial permeability transition is a central coordinating event of apoptosis. J Exp Med 1996;184:1155-1160.
28. Green DR, Reed JC. Mitochondria and apoptosis. Science 1998;281:1309-1312.
29. Desagher S, Osen-Sand A, Nichols A, et al. Bid-induced conformational change of Bax is responsible for mitochondrial cytochrome c release during apoptosis. J Cell Biol 1999;144:891-901.
30. Narita M, Shimizu S, Ito T, et al. Bax interacts with the permeability transition pore to induce permeability transition and cytochrome c release in isolated mitochondria. Proc Natl Acad Sci USA 1998;95:14681-14686.
31. Basanez G, Nechushtan A, Drozhinin O, et al. Bax, but not Bcl-xL, decreases the lifetime of planar phospholipid bilayer membranes at subnanomolar concentrations. Proc Natl Acad Sci USA 1999;96:5492-5497.
32. Luo X, Budihardjo I, Zou H, et al. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 1998;94:481-490.
33. Hu R, Zhou S, Li X. Altered Bcl-2 and Bax expression is associated with cultured first trimester human cytotrophoblasts apoptosis induced by hypoxia. Life Sci 2006;79:351-355.
34. Levy R, Smith SD, Chandler K, et al. Apoptosis in human cultured trophoblasts is enhanced by hypoxia and diminished by epidermal growth factor. Am J Physiol Cell Physiol 2000;278:C982-C988.
35. Stepan H, Leo C, Purz S, et al. Placental localization and expression of the cell death factors BNip3 and Nix in preeclampsia, intrauterine growth retardation and HELLP syndrome. Eur J Obstet Gynecol Reprod Biol 2005;122:172-176.
36. Soleymanlou N, Wu Y, Wang JX, et al. A novel Mtd splice isoform is responsible for trophoblast cell death in pre-eclampsia. Cell Death Differ 2005;12:441-452.
37. Crocker IP, Kenny LC, Thornton WA, et al. Excessive stimulation of poly(ADP-ribosyl)ation contributes to endothelial dysfunction in pre-eclampsia. Br J Pharmacol 2005;144:772-780.
38. Johansen M, Redman CW, Wilkins T, et al. Trophoblast deportation in human pregnancy - its relevance for pre-eclampsia. Placenta 1999;20:531-539.
39. Chua S, Wilkins T, Sargent I, et al. Trophoblast deportation in pre-eclamptic pregnancy. Br J Obstet Gynaecol 1991;98:973-979.
40. Robinson NJ, Baker PN, Jones CJ, et al. A role for tissue transglutaminase in stabilization of membrane-cytoskeletal particles shed from the human placenta. Biol Reprod 2007;77:648-657.
41. Gupta AK, Rusterholz C, Huppertz B, et al. A comparative study of the effect of three different syncytiotrophoblast microparticles preparations on endothelial cells. Placenta 2005;26:59-66.
42. Kertesz Z, Hurst G, Ward M, et al. Purification and characterization of a complex from placental syncytiotrophoblast microvillous membranes which inhibits the proliferation of human umbilical vein endothelial cells. Placenta 1999;20:71-79.
43. Kingdom JC, Kaufmann P. Oxygen and placental villous development: origins of fetal hypoxia. Placenta 1997;18:613-621, discussion 623-626.
44. Mayhew TM. Changes in fetal capillaries during preplacental hypoxia: growth, shape remodelling and villous capillarization in placentae from high-altitude pregnancies. Placenta 2003;24:191-198.
45. Odorisio T, Schietroma C, Zaccaria ML, et al. Mice overexpressing placenta growth factor exhibit increased vascularization and vessel permeability. J Cell Sci 2002;115:2559-2567.
46. Suri C, McClain J, Thurston G, et al. Increased vascularization in mice overexpressing angiopoietin-1. Science 1998;282:468-471.
47. Geva E, Ginzinger DG, Zaloudek CJ, et al. Human placental vascular development: vasculogenic and angiogenic (branching and nonbranching) transformation is regulated by vascular endothelial growth factor-A, angiopoietin-1, and angiopoietin-2. J Clin Endocrinol Metab 2002;87:4213-4224.
48. Bujold E, Romero R, Chaiworapongsa T, et al. Evidence supporting that the excess of the sVEGFR-1 concentration in maternal plasma in preeclampsia has a uterine origin. J Matern Fetal Neonatal Med 2005;18:9-16.
49. Brownbill P, McKeeman GC, Brockelsby JC, et al. Vasoactive and permeability effects of vascular endothelial growth factor-165 in the term in vitro dually perfused human placental lobule. Endocrinology 2007;148:4734-4744.
50. Martin de Aguilera E, Vila JM, Irurzun A, et al. Endothelium-independent contractions of human cerebral arteries in response to vasopressin. Stroke 1990;21:1689-1693.